Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Generex and Mayo expand collaboration for vaccine studies
Antigen Express previously entered into an agreement with Mayo Clinic to work with Keith Knutson, an expert in the field of peptide vaccines in breast cancer. The current
Antigen Express previously entered into an agreement with Mayo Clinic to work with Keith Knutson, an expert in the field of peptide vaccines in breast cancer. The current
Duke, which will become the first academic medical center in the country to use the Alphadas system, believe the technology has the potential to be a more accurate,
The recommendation has been granted for the oral tablet, oral syrup and intravenous formulations. The Committee for Medicinal Products for Human Use decision is supported by data from
ProStrakan Group, an international speciality pharmaceutical is Orexo’s exclusive partner for sales and marketing of Abstral/Rapinyl in Europe. Abstral/Rapinyl will be launched in Sweden in the third quarter
Enrollment of the first patients in the independent, blind, multicenter study began earlier, which will include patients from a large children’s hospital. The study is focused on patients
Chester Labs, based in Cincinnati, will continue to operate as an independent operating entity under the name Chester Packaging. John Armstrong, president of Chester Packaging, said: “Our new
Beginning in the third quarter of 2008, BodyTel’s new partner Sanisa will begin offering BodyTel’s blood glucose monitoring and diabetes management system, GlucoTel, in Spain and Portugal. Pursuant
Injectible Tobramycin is used in the initial empirical therapy for mechanically-ventilated patients (VAP) and is also well known for its nephrotoxicity. AlphaRx’s Zysolin is intended to replace injectible
BMP Sunstone will market and distribute Ferriprox under its five-year licensing agreement with Apotex. As part of the launch, the company has held physician seminars in cities throughout
Impliant had voluntarily suspended all clinical activities in September 2007 following one device-related failure. After an extensive investigation conducted by a third-party expert in medical device retrievals and